Assessment of a Tool for Decision Making in Case of Worsening Condition of Cancer Patients (CBP-Aggrav)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Observational two year study to evaluate the utility of a decision-support sheet on how to proceed in case of aggravation of a patient's condition with advanced disease.
Condition or disease
Other: observational study
Prospective and multicenter study conducted in the Rhône-Alpes-Auvergne area. All patients suffering from lung cancer admitted to a pulmonology unit in 2014 will be included. This document will be used if a decision to withhold life-sustaining treatment is decided. Investigators will assess the relationship between the planned intensity of care and those established when the patient develops an organ failure. Patient characteristics and factors associated with proposed levels and types of care will be analyzed. Patient and family opinions will be obtained after 3 months. The number of subjects is 468.
Emergent Serious Adverse Events [ Time Frame: 1 year and a half ]
The main objective of this study is to assess the relationship between the planned intensity of care and those established when the patient develops organ failure. The agreement will be assessed using Cohen's kappa coefficient .
Secondary Outcome Measures :
Patient feeling assessment using phone interview questionnaire [ Time Frame: 3 months after patient inclusion ]
Patients will be contacted by the investigator, to evaluate their feeling according to the collect of their opinion and wishes using a phone interview questionnaire within 30 minutes duration
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 [ Time Frame: first day ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Lung cancer patients will be recruited in the appreciation of the doctor (Md) of the service
Any patient with lung cancer, hospitalized in pulmonology unit in one of the participating centers.
Patient who requires a decision to withhold life-sustaining treatment
One patient can be included at each hospitalization.
Refusal of participation of the patient in the study